key: cord-0710865-srx5b90l
authors: Tahir, Mohammed
title: Coronavirus genomic nsp14‐ExoN, structure, role, mechanism, and potential application as a drug target
date: 2021-04-23
journal: J Med Virol
DOI: 10.1002/jmv.27009
sha: 0a2006d1e6bddbeb0963421e52c85917a20a9a10
doc_id: 710865
cord_uid: srx5b90l

The recent coronavirus disease 2019 (COVID‐19), causing a global pandemic with devastating effects on healthcare and social‐economic systems, has no special antiviral therapies available for human coronaviruses (CoVs). The severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2) possesses a nonstructural protein (nsp14), with amino‐terminal domain coding for proofreading exoribonuclease (ExoN) that is required for high‐fidelity replication. The ability of CoVs during genome replication and transcription to proofread and exclude mismatched nucleotides has long hindered the development of anti‐CoV drugs. The resistance of SARS‐CoV‐2 to antivirals, especially nucleoside analogs (NAs), shows the need to identify new CoV inhibition targets. Therefore, this review highlights the importance of nsp14‐ExoN as a target for inhibition. Also, nucleoside analogs could be used in combination with existing anti‐CoV therapeutics to target the proofreading mechanism.

Middle East Respiratory Syndrome coronavirus (MERS-CoV). All three of these viruses raised as novel coronaviruses, are causing respiratory diseases and transmitted from animals to humans (zoonotic viruses), and cause respiratory diseases. 3 SARS-CoV-2 is closest (88%) to two SARSlike bat-derived CoVs (bat-SL-CoVZC45 and bat-SL-CoVZXC21), with (79%) overall SARS-CoV sequence identity and (50%) MERS-CoV identity 4 The SARS-CoV polycistronic RNA genome encodes 14 open reading frames (ORFs), some of which overlap. 1 The genomes 5′ end is capped and has a 3′ poly(A) tail with short 5′ and 3′ untranslated region sequences forming regulatory stem-loop structures and a single leader sequence proximal to the 5′ end.

Two-thirds of the genome encodes two large polyproteins, pp1a and pp1ab, that are cleaved into 16 nonstructural proteins. The last one-third of the genome encodes structure and additional proteins ( Figure 1 ). The bifunctional nsp14 contains an N-terminal 3′-to-5′ exoribonuclease (ExoN) and a C-terminal N7-methyltransferase (N7-MTase) domain. In the 3′-to-5′ direction, nsp14 catalyzes nucleoside monophosphate excision from nucleic acids, using a mechanism that relies on two divalent metal ions and a reactive water molecule. This exonucleolytic activity is crucial for the Coronavirus replication proofreading activity, a property lacking in other RNA viruses that improve its fidelity replication and has played an essential role in nidoviral evolution and genome expansion. 1 The first proofreading protein identified in an RNA virus is the coronavirus ExoN, and targeting ExoN is a promising strategy to develop new coronavirus inhibitors and antiviral sensitizers. 5 The development of anti-CoV drugs has long been hampered by the ability of CoVs during genome replication and transcription to proofread and eliminate mismatched nucleotides (Table 1 ).

The replication of RNA virus has a high error rate (or low viral fidelity), resulting in the virus living as diverse genome mutant populations or "quasispecies." RNA viruses can adapt to various replicative environments and selective stresses due to low replicative fidelity, however, a disastrous error could lead to viral extinction. This factor threatens the F I G U R E 1 Single-stranded RNA genome of severe acute respiratory syndrome coronavirus 2. Two-thirds of the genome encodes two major polyproteins, pp1a and pp1ab, which are divided into 16 nonstructural proteins 40 T A B L E 1 Role of nonstructural proteins of SARS-CoV-2

Function Reference

It plays a role in host-range restriction, countering the innate antiviral response of the host, and suppressing apoptosis induction during the early stages of infection to promote viral growth.

Jauregui et al. 6 and Narayanan et al. 7

It is involved in disrupting intracellular host signaling. Cornillez-Ty et al. 8

It is suggested that it facilitates mRNA transcript translation while suppressing host protein synthesis.

Lu et al. 9 , Anand et al. 10 27 The distinctive 3′ to 5′ exoribonuclease (ExoN) proofreading feature is an additional obstacle to the production of nucleoside analogs (NAs) as antivirals against CoVs. Proofreading activities that protect the virus from mutagenesis are provided by nonstructural protein 14. 5 Within the family Coronaviridae, nsp14 is strongly conserved. 28 In Group 2 coronaviruses and possibly all coronaviruses, nsp14-ExoN is involved in RNA proofreading, and the acquisition of ExoN function is necessary for the achievement and preservation of broad genomes of coronaviruses. 29 

Nsp14 is a 60 kDa bifunctional enzyme involved in replication fidelity with an N-terminal ExoN domain and N7-methyltransferase (N7-MTase)

C-terminal domain that is involved in messenger RNA (mRNA) capping. 26 SARS-CoV-2 and SARS-CoV nsp14 share more than 95% similarity in amino acid sequence. 30 Also, nsp14 is involved in many other virus life cycles and pathogenicity processes, including recombination of the viral genome and control of innate immune responses. 31 The exoribonucleolytic activity of nsp14 3ʹ−5ʹ relies on metal ions, preferably Mg 2+ over Mn 2+ , Co 2+ , and Zn 2+ promote residual activity, while catalysis was not supported by Ca 2+ , Ni 2+ , and Cu 2+ . 32 

The C-terminal N7-MTase domain contains a DxG S-adenosyl-Lmethionine (SAM)-a binding motif conserved among CoVs and is involved in mRNA capping and host immune response evasion. 33 In pre-mRNA splicing, mRNA export, RNA stability, this cap structure plays essential roles by blocking degradation by the 5ʹ−3ʹ exoribonuclease. Translational initiation by promoting the 4E (eIF4E) binding initiation factor of eukaryotic translation, 34 and escapes from the cellular innate immune system recognition. 35 In cytoplasmic granular compartments, host and viral RNA molecules missing the 5ʹ cap structure are degraded. 36 In SARS-CoV nsp14, mutations in the DxG motif specifically eliminate the activity of N7-MTase that is essential for the formation of mRNA caps, and they have an exact detrimental effect on replication without disrupting the activity of ExoN, demonstrating the importance of this enzymatic function of nsp14. 33 

The activity of nsp14 exoribonuclease resides in the N terminal. 37 X-ray crystallography of the nsp14/nsp10 complex and its functional ligands were able to identify a range of main factors that highlighted distinct differences between nsp14 and its DEDD superfamily homologs and shed light on several characteristics of the structure and function of the protein. 28 Ma et al. 28 compared the nsp14 ExoN active sites with proofreading homologs of E. coli DNA polymerase I Klenow fragment and the polymerase III subunit ε. They reported that Asp90, Glu92, Glu191, His268, and Asp2733 were the catalytic residues in nsp14. Glu191 replaced the Asp424 of the Klenow fragment and Asp103 of the ε subunit. This makes nsp14 a "DEED outlier." Furthermore, Asp243, a catalytic center, is highly preserved and mutating it inhibit nsp14 activity, although its function has yet to be deciphered. 40 nsp14 has exoribonuclease activity and is capable of degrading ssRNA in 3ʹ-5ʹ directions. 23 The nsp14 activity requires divalent metal ions as a cofactor and it is essential to have a secondary structure of the RNA substrate. Furthermore, mutating the conserved D/E residues showed severe defects in viral RNA synthesis, and no viable virus could be recovered. 23 Two Mg 2+ ions are expected to coordinate the five catalytic DEEDh residues that aid in removing misincorporated nucleotides. To activate a nucleophilic attack on the phosphate of the substrate nucleotide, MgA must activate a water molecule, and MgB would then promote the product's exit. 40 

In many processes during the viral infection cycle, interactions between viral proteins play crucial roles. A yeast two-hybrid screen of intraviral protein-protein interactions revealed nsp10 as an interacting partner of nsp14. 41 Experiments in vitro in E. coli has identified that dsRNA with a 30 mismatch is the preferred substrate of the nsp10-bound nsp14 that mimics a faulty replication product.

Although nsp14 alone has exoribonuclease activity, this study also showed more than a 35-fold increase in nsp14 activity when bound to nsp10, indicating that nsp10 has a role in stabilizing the active site of ExoN in the correct conformation for catalysis of the substrate. 18 The interaction between nsp10 and nsp14 is figuratively equivalent to a hand (nsp14) over a fist (nsp10) (Figure 2 ). During exoribonuclease assays, the addition of nsp10 to the complex increased the ExoN activity, indicating that nsp10 improves ExoN activity in situ in the active complex. 42 In the presence of nsp10, ExoN active site residues are adequately positioned and form a highly active ExoN, as determined by the distance observed between catalytic residues. 38 Mutations in the nsp10 domain that interact with nsp14 resulted in a decrease in viral replication fidelity. The complexed protein structure showed that nsp10 confers structural integrity and stability to nsp14's ExoN domain. 18 In the absence of nsp10, the ExoN catalytic pocket partly collapses, accounting for the poor ExoN behavior of nsp14 alone. 38 

A study revealed significant differences between nsp14 ExoN and other members of the DEDD exonuclease superfamily in addition to the revised catalytic motif. 39 Although the core structural elements are similar, nsp14 ExoN has two zinc fingers essential for exoribonuclease activity and a site of interaction with nsp10. Zinc finger 2 is located near the catalytic core, and the domain is disrupted by the action of the enzyme via C261A or H264R mutations, meaning that it has a role in catalysis. On the other hand, zinc finger 1 mutation result in insoluble proteins of nsp14 when expressed in E. coli, and this, together with its composition, indicated the role for SARS-CoV nsp14 in structural stability. 40 The proximity of zinc finger 1 to the interaction site of nsp10 could influence the interaction between nsp10 and nsp14 and thus mRNAs (sgmRNAs) with typical ends of 5ʹ and 3ʹ. 46 Therefore, as a natural part of their replication, CoVs, perform recombination, creating complex populations of recombined RNA molecules. 31 Gribble et al. 31 and their known inhibitory effects on in vitro beta coronaviruses 49 and in patients. 50 As potential proofreading inhibitors of ExoN 

Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage

Virus Taxonomy: Ninth Report of the International Committee on Taxonomy of Viruses

Characteristics of SARS-CoV-2 and COVID-19

Remdesivir and SARS-CoV-2: structural requirements at both nsp12 RdRp and nsp14 exonuclease active-sites

Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics

Identification of residues of SARS-CoV nsp1 that differentially affect inhibition of gene expression and antiviral signaling

Coronavirus nonstructural protein 1: common and distinct functions in the regulation of host and viral gene expression

Severe acute respiratory syndrome coronavirus nonstructural protein 2 interacts with a host protein complex involved in mitochondrial biogenesis and intracellular signaling

Sequence analysis and structural prediction of the severe acute respiratory syndrome coronavirus nsp5

Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs

Chimeric exchange of coronavirus nsp5 proteases (3CLpro) identifies common and divergent regulatory determinants of protease activity

Coronavirus NSP6 restricts autophagosome expansion

Evolutionary analysis of SARS-CoV-2: how mutation of non-structural protein 6 (NSP6) could affect viral autophagy

Localization and membrane topology of coronavirus nonstructural protein 4: involvement of the early secretory pathway in replication

Nidovirus papain-like proteases: multifunctional enzymes with protease, deubiquitinating and deISGylating activities

Nonstructural proteins 7 and 8 of feline coronavirus form a 2:1 heterotrimer that exhibits primerindependent RNA polymerase activity

Coronavirus infectious bronchitis virus non-structural proteins 8 and 12 form stable complex independent of the non-translated regions of viral RNA and other viral proteins

Coronavirus Nsp10, a critical co-factor for activation of multiple replicative enzymes

RNA 3'-end mismatch excision by the severe acute respiratory syndrome coronavirus nonstructural protein nsp10/nsp14 exoribonuclease complex

Processing of open reading frame 1a replicase proteins nsp7 to nsp10 in murine hepatitis virus strain A59 replication

Proteolytic processing of polyproteins 1a and 1ab between non-structural proteins 10 and 11/12 of Coronavirus infectious bronchitis virus is dispensable for viral replication in cultured cells

The RNA polymerase activity of SARS-coronavirus nsp12 is primer dependent

Discovery of an RNA virus 3′→5′ exoribonuclease that is critically involved in coronavirus RNA synthesis

Biochemical characterization of exoribonuclease encoded by SARS coronavirus

The severe acute respiratory syndrome coronavirus Nsp15 protein is an endoribonuclease that prefers manganese as a cofactor

Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase

Antiviral strategies based on lethal mutagenesis and error threshold

Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex

Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing

The enzymatic activity of the nsp14 exoribonuclease is critical for replication of MERS-CoV and SARS-CoV-2

The coronavirus proofreading exoribonuclease mediates extensive viral recombination

New targets for drug design: importance of nsp14/nsp10 complex formation for the 3'-5' exoribonucleolytic activity on SARS-CoV-2

Mutagenesis of S-adenosyl-L-methionine-binding residues in coronavirus nsp14 N7-methyltransferase demonstrates differing requirements for genome translation and resistance to innate immunity

Viral and Cellular mRNA Capping: Past and Prospects

A brilliant disguise for self RNA: 5'-end and internal modifications of primary transcripts suppress elements of innate immunity

Decapping the message: a beginning or an end

Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA

Biochemical characterization of exoribonuclease encoded by SARS coronavirus

Coronavirus RNA proofreading: molecular basis and therapeutic targeting

Genome-wide analysis of protein-protein interactions and involvement of viral proteins in SARS-CoV replication

SARS-CoV ORF1b-encoded nonstructural proteins 12-16: replicative enzymes as antiviral targets

Mutagenesis of Coronavirus nsp14 reveals its potential role in modulation of the innate immune response

Recombination and lineage-specific mutations led to the emergence of SARS-CoV-2

Two novel porcine epidemic diarrhea virus (PEDV) recombinants from a natural recombinant and distinct subtypes of PEDV variants

Continuous and discontinuous RNA synthesis in coronaviruses

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys

Drug repurposing strategies for COVID-19

Potential antivirals and antiviral strategies against SARS coronavirus infections

Antiviral activity of glycyrrhizic acid derivatives against SARS−coronavirus

Combining SARS-CoV-2 proofreading exonuclease and RNA-dependent RNA polymerase inhibitors as a strategy to combat COVID-19: a high-throughput in silico screen. OSF Reprints. 2020. How to cite this article: Tahir M. Coronavirus genomic nsp14-ExoN, structure, role, mechanism, and potential application as a drug target

The authors declare that there are no conflict of interests.

http://orcid.org/0000-0003-1588-469X